Bringing you live news and features since 2006 

ETFMG adds biotech fund to thematic ETF offering

RELATED TOPICS​

Thematic ETF issuer ETFMG has launched the ETFMG Treatments, Testing and Advancements ETF (GERM), which seeks to answer investor demand for direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. The first-to-market methodology behind the Fund focuses on the advancements in the infectious disease sub-sector of biotech with targeted exposure to US-listed companies at the forefront of R&D, vaccines, therapies and testing technologies.

GERM provides access to both established providers as well as the “unsung heroes” of the biotech and life sciences market. The frequency and diversity of disease outbreaks, similar to COVID-19, have grown steadily for the past 30 years.

“Our global health depends a great deal on innovation and discovery that will address how to prevent further infection with enhanced immune therapies or vaccines,” says Reynold A Panettieri, Jr, MD, Professor of Medicine, Vice Chancellor for Translational Medicine and Science at Rutgers University, and Director of the Institute for Translational Medicine and Science. “GERM offers a unique approach that embraces cutting-edge technologies through cooperativity among Big/Small Pharma and biotech that can nimbly leverage discoveries and translate them into commercialised and impactful assets.”

“GERM represents an investment theme that is much more than topical, it provides unique exposure to a previously underrepresented growth sector within biotech. We are excited to bring this product to US investors,” says Sam Masucci, CEO and Founder of ETFMG.
 

Latest News

ETF data consultant ETFGI reports that assets invested in the global ETF industry reached a new record of USD12.71 trillion..
Calastone has published an ETF white paper which examines several of the processes that take place across the lifecycle of..
Adapting product lines to fit into changing methodologies and meet shifting demand is essential to remaining relevant in the industry..
Investors urgently need greater access to diversified investment strategies aligned with the Paris Agreement on climate change if the world..

Related Articles

Taylor Krystkowiak, Themes ETFs
Themes ETFs opened its doors in December 2023, with an introductory suite of 11 ETFs – seven thematic and four...
Konrad Sippel, Solactive
At the end of March, financial index specialist, Solactive, published its 2024 annual report on future trends.  ...
Lorraine Sereyjol-Garros, BNP Paribas
Following changes to the French Monetary and Financial Code and of the French market authority AMF’s General Regulation, it is...
Ed Rosenberg, Texas Capital
Texas Capital Bank first opened its doors back in December 1998 and nowadays offers wealth-management services, as well as commercial,...
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by